Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Collegium Pharmaceutical, Inc. COLL

Set alert

Price alert · COLL

All alert types
23.68 USD -0.12 -0.50%

At close · Nov 2

23.68 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
23.69 × 2
Ask
23.71 × 2
23.27 Day range 24.08
21.43 52-week range 50.79
YTD
-48.86%
1 year
-34.22%
Open
23.96
Prev close
23.80
Mkt cap
770.92M
Vol
600.67K
Avg vol
820.34K
EPS
1.27
P/E
18.65
Div yield
0.00%
More statistics
Low
23.27
High
24.08
Forward P/E
4.86
Beta
0.73
Short ratio
0.00
Inst. own
128.23%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
34.80
200-d avg
39.23
1y target
53.60

1M chart

Chart tools
Interval
1m5m15m30m

Signals (8)
NameDateAgo
SMA: BullishOct 29, 20264 days ago
SMA: BullishOct 28, 20265 days ago
SMA: BearishOct 27, 20266 days ago
SMA: BullishOct 14, 20262 weeks ago
SMA: BearishOct 13, 20262 weeks ago
RSI: OversoldOct 13, 20262 weeks ago
SMA: BullishOct 8, 20263 weeks ago
RSI: OversoldOct 5, 20264 weeks ago

Financial health

Altman Z-Score

0.95 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-3 / 5 overall

  • DCF 3
  • Return on Equity 4
  • Return on Assets 3
  • Debt / Equity 1
  • P/E 2
  • P/B 2

Valuation

P/E 23.4×
FY 2016: -4.0×FY 2017: -7.5×FY 2018: -14.4×FY 2019: -85.8×FY 2020: 25.7×FY 2021: 9.1×FY 2022: -31.4×FY 2023: 19.2×FY 2024: 13.4×FY 2025: 23.4×
FY 2016 5y median 13.4× FY 2025
P/S 1.9×
FY 2016: 221×FY 2017: 19.6×FY 2018: 2.0×FY 2019: 2.3×FY 2020: 2.2×FY 2021: 2.4×FY 2022: 1.7×FY 2023: 1.8×FY 2024: 1.5×FY 2025: 1.9×
FY 2016 5y median 1.8× FY 2025
P/B 4.9×
FY 2016: 2.8×FY 2017: 5.4×FY 2018: 6.2×FY 2019: 7.9×FY 2020: 3.7×FY 2021: 3.2×FY 2022: 4.0×FY 2023: 5.3×FY 2024: 4.0×FY 2025: 4.9×
FY 2016 5y median 4.0× FY 2025
P/FCF 4.5×
FY 2016: -4.8×FY 2017: -8.2×FY 2018: 3.9×FY 2019: 32.3×FY 2020: -2.5×FY 2021: 6.4×FY 2022: 6.4×FY 2023: 3.8×FY 2024: 4.5×FY 2025: 4.5×
FY 2016 5y median 4.5× FY 2025
EV/EBITDA 5.4×
FY 2016: -2.4×FY 2017: -5.9×FY 2018: 4.7×FY 2019: -85.3×FY 2020: 6.6×FY 2021: 8.4×FY 2022: 7.6×FY 2023: 4.8×FY 2024: 5.0×FY 2025: 5.4×
FY 2016 5y median 5.4× FY 2025
EV/Sales 2.8×
FY 2016: 134×FY 2017: 15.5×FY 2018: 1.5×FY 2019: 1.8×FY 2020: 2.5×FY 2021: 2.6×FY 2022: 2.8×FY 2023: 2.6×FY 2024: 2.7×FY 2025: 2.8×
FY 2016 5y median 2.7× FY 2025
FCF Yield 22.3%
FY 2016: -20.7%FY 2017: -12.2%FY 2018: 25.7%FY 2019: 3.1%FY 2020: -40.6%FY 2021: 15.6%FY 2022: 15.6%FY 2023: 26.4%FY 2024: 22.0%FY 2025: 22.3%
FY 2016 5y median 22.0% FY 2025

Profitability

Gross Margin 59.3%
FY 2016: 87.6%FY 2017: 90.9%FY 2018: 40.9%FY 2019: 34.7%FY 2020: 58.0%FY 2021: 54.4%FY 2022: 45.2%FY 2023: 57.5%FY 2024: 59.8%FY 2025: 59.3%
FY 2016 5y median 57.5% FY 2025
Operating Margin 24.0%
FY 2016: -5498.7%FY 2017: -264.9%FY 2018: -7.4%FY 2019: -8.0%FY 2020: 18.1%FY 2021: 6.4%FY 2022: 7.2%FY 2023: 29.5%FY 2024: 26.9%FY 2025: 24.0%
FY 2016 5y median 24.0% FY 2025
Net Margin 8.1%
FY 2016: -5504.1%FY 2017: -262.9%FY 2018: -14.0%FY 2019: -7.7%FY 2020: 8.6%FY 2021: 25.8%FY 2022: -5.4%FY 2023: 8.5%FY 2024: 11.0%FY 2025: 8.1%
FY 2016 5y median 8.5% FY 2025
ROE 20.8%
FY 2016: -69.8%FY 2017: -71.9%FY 2018: -42.7%FY 2019: -26.0%FY 2020: 14.4%FY 2021: 35.2%FY 2022: -12.8%FY 2023: 24.6%FY 2024: 30.2%FY 2025: 20.8%
FY 2016 5y median 24.6% FY 2025
ROIC 10.2%
FY 2016: -66.4%FY 2017: -71.5%FY 2018: -19.6%FY 2019: -21.8%FY 2020: 12.0%FY 2021: -80.9%FY 2022: 3.2%FY 2023: 12.2%FY 2024: 9.8%FY 2025: 10.2%
FY 2016 5y median 9.8% FY 2025
ROA 3.8%
FY 2016: -58.1%FY 2017: -55.2%FY 2018: -13.4%FY 2019: -7.4%FY 2020: 4.2%FY 2021: 10.3%FY 2022: -2.1%FY 2023: 4.2%FY 2024: 4.2%FY 2025: 3.8%
FY 2016 5y median 4.2% FY 2025

Growth (YoY)

Revenue 23.6%
FY 2016: 0.0%FY 2017: 1564.3%FY 2018: 884.7%FY 2019: 5.8%FY 2020: 4.5%FY 2021: -10.7%FY 2022: 67.6%FY 2023: 22.2%FY 2024: 11.4%FY 2025: 23.6%
FY 2016 FY 2025
Operating Income 10.1%
FY 2016: -249.7%FY 2017: 19.8%FY 2018: 72.6%FY 2019: -14.8%FY 2020: 336.8%FY 2021: -68.7%FY 2022: 89.0%FY 2023: 401.1%FY 2024: 1.8%FY 2025: 10.1%
FY 2016 FY 2025
EPS (diluted) -7.0%
FY 2016: -93.0%FY 2017: 36.3%FY 2018: 51.8%FY 2019: 79.8%FY 2020: 416.7%FY 2021: 144.7%FY 2022: -139.8%FY 2023: 274.3%FY 2024: 44.2%FY 2025: -7.0%
FY 2016 FY 2025
Free Cash Flow 61.1%
FY 2016: -255.8%FY 2017: 12.8%FY 2018: 313.3%FY 2019: -85.3%FY 2020: -1411.0%FY 2021: 136.3%FY 2022: 20.7%FY 2023: 123.7%FY 2024: -25.9%FY 2025: 61.1%
FY 2016 FY 2025

Financial Health

Current Ratio 1.6×
FY 2016: 6.9×FY 2017: 4.2×FY 2018: 1.3×FY 2019: 1.3×FY 2020: 1.2×FY 2021: 1.1×FY 2022: 1.0×FY 2023: 1.2×FY 2024: 0.9×FY 2025: 1.6×
FY 2016 5y median 1.1× FY 2025
Quick Ratio 1.5×
FY 2016: 6.9×FY 2017: 4.2×FY 2018: 1.2×FY 2019: 1.2×FY 2020: 1.1×FY 2021: 1.1×FY 2022: 0.9×FY 2023: 1.1×FY 2024: 0.9×FY 2025: 1.5×
FY 2016 5y median 1.1× FY 2025
Debt / Equity 3.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.1×FY 2019: 0.2×FY 2020: 1.4×FY 2021: 1.3×FY 2022: 3.6×FY 2023: 3.5×FY 2024: 3.8×FY 2025: 3.1×
FY 2016 5y median 3.5× FY 2025
Net Debt / EBITDA 1.7×
FY 2016: 1.6×FY 2017: 1.6×FY 2018: -1.5×FY 2019: 23.4×FY 2020: 0.8×FY 2021: 0.8×FY 2022: 3.1×FY 2023: 1.4×FY 2024: 2.3×FY 2025: 1.7×
FY 2016 5y median 1.7× FY 2025
Interest Coverage 2.3×
FY 2016: -1001×FY 2017: 0.0×FY 2018: -1.0×FY 2019: -26.1×FY 2020: 1.9×FY 2021: 0.8×FY 2022: 0.5×FY 2023: 2.0×FY 2024: 2.3×FY 2025: 2.3×
FY 2016 5y median 2.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 6.5%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: -26.1%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31